Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04878952 · ClinicalTrials.gov registry record · NA
Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer
A NA study, sponsored by NRG Oncology.
- Terminated
- Registry status
- NA
- Development phase
- 3
- Enrollment target
NCT04878952: Clinical Trial NA study, sponsored by NRG Oncology.
NCT04878952 is a NA study that was terminated before completion, run by NRG Oncology. The registered enrollment target is 3 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04878952, a NA study, was terminated before completion, sponsored by NRG Oncology.
- TERMINATED
- Registry status
- NA
- Development phase
- 3 participants
- Enrollment target
Study Summary
This trial will examine if the monitoring of daily step counts during a course of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer will enable clinicians to deliver improved supportive care and reduce the rate of adverse events during the course of radiation treatment.
Primary Outcome
Occurrence of hospital admission during radiation treatment or within 1 month after radiotherapy completion.
Interventions
- OTHER Garmin Vivofit Activity Tracker
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2021-08-26 |
| Est. Completion | 2024-08-12 |
| Phase | NA |
Why NCT04878952 stopped before completion
NCT04878952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Garmin Vivofit Activity Tracker is the first listed.
NCT04878952 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04878952 about?
NCT04878952 is a clinical study titled "Testing the Addition of Activity Monitoring With a Wearable Electronic Device to Improve Patient Care During Treatment for Lung Cancer". This trial will examine if the monitoring of daily step counts during a course of concurrent chemoradiotherapy for locally advanced non-small cell lung cancer will enable clinicians to deliver improved supportive care and reduce the rate of adverse events during the course of radiation treatment.
What is the current status of trial NCT04878952?
This trial is currently terminated. It is a NA study. The enrollment target is 3 participants. The study started on 2021-08-26. Estimated completion is 2024-08-12.
What interventions are being tested in trial NCT04878952?
The interventions under investigation include: Garmin Vivofit Activity Tracker (OTHER).
Who is sponsoring clinical trial NCT04878952?
This trial is sponsored by NRG Oncology, which has 64 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04878952's enrollment target sits among peer trials
3 1996th of 2000 higher than 4 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI